Kirsten Axelsen

Opinion author

Kirsten Axelsen is a biopharmaceutical consultant as well as a visiting scholar with the American Enterprise Institute and policy advisor to DLA Piper and Charles River Associates.

U.S. Capitol surrounded by money and pill bottles/Taylor Tieden for BioSpace

Opinion

Don’t Import Bad Policy Ideas on Drug Pricing

Suggestions that the U.S. should emulate other countries on drug price controls or patents obscure how our present policies have allowed drug development to flourish.

November 13, 2024

4 min read

Kirsten Axelsen